Back
Armata Pharmaceuticals Stock Price Chart
Sponsored
ARMP
Sponsored
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Buy
69
ARMP
Armata Pharmaceuticals
Last Price:
2.36
Seasonality Move:
17.29%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!- The current trend is relatively stagnant and ARMP is experiencing buying pressure, which is a positive indicator for future bullish movement.
Armata Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.34 | Buy |
20-day SMA: | 2.35 | Buy |
50-day SMA: | 2.34 | Buy |
200-day SMA: | 2.9 | Sell |
8-day EMA: | 2.34 | Buy |
20-day EMA: | 2.34 | Buy |
50-day EMA: | 2.38 | Sell |
200-day EMA: | 2.64 | Sell |
Armata Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 50.37 | Buy |
Chaikin Money Flow: | 5594 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.31 - 2.39) | Sell |
Bollinger Bands (100): | (2.27 - 2.81) | Sell |
Armata Pharmaceuticals Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Armata Pharmaceuticals Stock
Is Armata Pharmaceuticals Stock a Buy?
- Armata Pharmaceuticals share price is 2.35 while ARMP 8-day simple moving average is 2.34, which is a Buy signal.
- The stock price of ARMP is 2.35 while Armata Pharmaceuticals 20-day SMA is 2.35, which makes it a Buy.
- Armata Pharmaceuticals 50-day simple moving average is 2.34 while ARMP share price is 2.35, making it a Buy technically.
- ARMP stock price is 2.35 and Armata Pharmaceuticals 200-day simple moving average is 2.90, creating a Sell signal.
ARMP Technical Analysis vs Fundamental Analysis
Buy
69
Armata Pharmaceuticals (ARMP)
is a Buy
Is Armata Pharmaceuticals a Buy or a Sell?
-
Armata Pharmaceuticals stock is rated a Buy
The current Armata Pharmaceuticals [ARMP] share price is $2.35. The Score for ARMP is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
Armata Pharmaceuticals Stock Info
Market Cap:
85.03M
Price in USD:
2.35
Share Volume:
8.95K
Armata Pharmaceuticals 52-Week Range
52-Week High:
4.48
52-Week Low:
1.93
Buy
69
Armata Pharmaceuticals (ARMP)
is a Buy
Armata Pharmaceuticals Share Price Forecast
-
What is the Armata Pharmaceuticals stock price today?
The Armata Pharmaceuticals stock price is 2.35 USD today. -
Will ARMP stock go up or go down?
Armata Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Armata Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Armata Pharmaceuticals is not overvalued.
Is Armata Pharmaceuticals Stock a Buy?
- Armata Pharmaceuticals share price is 2.35 while ARMP 8-day exponential moving average is 2.34, which is a Buy signal.
- The stock price of ARMP is 2.35 while Armata Pharmaceuticals 20-day EMA is 2.34, which makes it a Buy.
- Armata Pharmaceuticals 50-day exponential moving average is 2.38 while ARMP share price is 2.35, making it a Sell technically.
- ARMP stock price is 2.35 and Armata Pharmaceuticals 200-day simple moving average is 2.64, creating a Sell signal.
Fundamental Analysis of Armata Pharmaceuticals
Is Armata Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and an increase next year of $0.52 per share.
Technical Analysis of Armata Pharmaceuticals
Should I short Armata Pharmaceuticals stock?
- ARMP Moving Average Covergence Divergence (MACD) indicator is -0, suggesting Armata Pharmaceuticals is a Sell
- Armata Pharmaceuticals Relative Strength Index (RSI) is 50.37, which suggest Armata Pharmaceuticals is overbought
- The Bollinger Bands (25) for Armata Pharmaceuticals is (2.31 - 2.39), which suggest Armata Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Armata Pharmaceuticals is (2.27 - 2.81), which suggest Armata Pharmaceuticals is a Sell
* Armata Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.